Navigation Links
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Date:11/1/2011

#160;Presentations will examine clinical data from challenging PCI subsets and preview new research on bioabsorbable drug delivery from the EVOLVE trial.
  • REPRISE Clinical Program for Lotus™ Valve System.  Ian Meredith, M.B.B.S., Ph.D., will present an update on the REPRISE clinical program, which is evaluating the Lotus™ Valve System, the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.  The Lotus Valve was developed by Sadra Medical, acquired by Boston Scientific in 2011.  The spotlight session begins at 8:58 a.m. in Room 135.  

  • Friday, November 11

  • Late-Breaking Trial: EVOLVE Endpoint Data.  Principal Investigator Ian Meredith, M.B.B.S., Ph.D., will present primary endpoint data from the EVOLVE trial during a late-breaking clinical session at 11 a.m. in the Main Arena.  EVOLVE is a prospective, randomized, non-inferiority trial that compares two dose formulations of everolimus on Boston Scientific's SYNERGY Coronary Stent to the PROMUS Element Everolimus-Eluting Coronary Stent in patients with de novo coronary artery lesions.  The SYNERGY Stent features the Company's proprietary platinum chromium alloy and uses a bioabsorbable polymer and everolimus drug combination to create an ultra-thin, uniform coating confined to the outer surface of the stent.  The Company plans to issue a press release announcing trial results at the conclusion of the presentation.

  • Late-Breaking Trial: COBRA Endpoint Data.   Subhash Banerjee, M.D., will present 12-month endpoint data from the COBRA trial during a late-breaking clinical session at 12:40 p.m. in the Main Arena.  COBRA is a prospective, randomized, multi-center trial that compares CryoPlasty® Therapy using the PolarCath™ Peripheral Dilatation System to conventional balloon angioplasty for the post-dilatation of
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
    3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
    4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
    5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
    8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
    9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
    10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
    11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2015)... , May 21, 2015 ... the addition of the "North American Active ... by Application (Surgical Wound, & Ulcer), by End-User ... 2019" report to their offering. ,     (Logo: ... market is estimated to grow at a CAGR ...
    (Date:5/21/2015)... -- Cardica, Inc. (Nasdaq: CRDC ) today announced that on ... company,s vice president of operations, was granted an option to ... per share exercise price of $0.43, the closing trading price ... to Cardica, Inc.,s Inducement Plan, which was approved by the ... of the Nasdaq Global Market for equity grants to induce ...
    (Date:5/21/2015)... CAMBRIDGE, England , May 21, ... zur Bekämpfung von Arzneimittelfälschungen - Zwecks ... eines Arzneimittelprüfdienstes wird auf EG-Mitgliedstaaten verwiesen, ... Pilotsysteme betrieben werden.  Wählen Sie ein ... Bei der Richtlinie zur Bekämpfung von ...
    Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
    ... The U.S. Food and Drug Administration today issued new ... needle-free clinical devices to administer influenza vaccinations. Based on ... ) immediately discontinued use of such clinical devices at ... The Kroger family of pharmacies and The Little ...
    ... HAYWARD, Calif., Oct. 21, 2011 Intarcia ... a letter of intent with Quintiles , the world,s ... 3 program for Intarcia,s ITCA 650 (DUROS® subcutaneous continuous delivery ... GLP-1 therapy to better address the unmet needs of the ...
    Cached Medicine Technology:Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 2Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 3Intarcia and Quintiles Sign Letter of Intent for Innovative Global Collaboration to Advance ITCA 650 in Type 2 Diabetes 4
    (Date:5/22/2015)... 22, 2015 Combination therapy, or ... for chronic obstructive pulmonary disorder (COPD) as the ... AstraZeneca plc as well as Germany’s Boehringer Ingelheim ... position. But will market payers, clinicians and patients ... products to completely new ones? , In spite ...
    (Date:5/22/2015)... Coordinating care for people with ... providers have not been reimbursed or rewarded for ... Medicare has paved the way by offering reimbursement ... launch of Oculus Health , an innovative ... the platform will now be able to easily ...
    (Date:5/22/2015)... 22, 2015 ZH Healthcare ... solutions, announced today that Bill Lane, joins ZH’s ... developer of BlueEHS,a first of its kind, Freemium ... customizable Electronic Health Records (EHR) with an integrated ... telemedicine-enabled comprehensive patient portal, and more. Combined with ...
    (Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... 16th sweetFrog store located in the Lone Star State. The ... Inc. 500 list of fastest growing companies in 2014. ... for 20 years and love the natural beauty and friendly ... Palestine, sweetFrog locations. “We are really excited about giving back ...
    (Date:5/22/2015)... May 22, 2015 In an effort ... and Sons is offering to donate $5 dollars for ... AC unit or water softening system. Customers have their ... and Sons gets business; and the Special Olympics receives ... Special Olympics helps over 4.4 million athletes, and boasts ...
    Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
    ... 2010) -- Nine-year-old Morgan LaRue is the first cancer patient ... magnetically lengthen her leg, sparing her the possibility of up ... and extension took place at Texas Children,s Cancer Center in ... Center or the device, please see http://bit.ly/MorganLaRue ., On ...
    ... a year in U.S., Canada, study says , FRIDAY, ... in public places across the United States and Canada ... otherwise would die of cardiac arrest each year, researchers ... for defibrillators in more limited setting, such as casinos ...
    ... movement, quality of life, researchers say , FRIDAY, April 16 ... small but significant improvements in their ability to move their ... finds. , The study, by the U.S. Department of ... New England Journal of Medicine , offers the strongest evidence ...
    ... ... in the body. , ... PA (Vocus) April 16, 2010 -- Researchers at Drexel University College of Medicine ... in breast cancer cells and is critical for cancer growth and movement. When researchers reduced ...
    ... ... 2010 targets in the fight against the disease, World Vision’s End Malaria campaign is leading ... to press American congressional leaders to keep investing in programs that are saving the lives ... ...
    ... ... Onyx M.D., announces that they now help physicians find government physician jobs as they ... agencies which provides a new source of locum tenens or temporary physician job opportunities ... ...
    Cached Medicine News:Health News:Texas Children's Cancer Center first in Texas to magnetically lengthen 9-year-old's leg as she grows 2Health News:Public Defibrillators Save Lives 2Health News:Public Defibrillators Save Lives 3Health News:Robot-Aided Therapy Can Help Patients Years After Stroke 2Health News:Scientists Report Key Finding in Breast Cancer Research 2Health News:Scientists Report Key Finding in Breast Cancer Research 3Health News:World Vision Malaria Experts Available for Comment as World Malaria Day Approaches April 25 2Health News:World Vision Malaria Experts Available for Comment as World Malaria Day Approaches April 25 3Health News:Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs 2Health News:Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs 3
    ... can be useful in the treatment of ... normalizing blood sugar. Post cataract surgery - ... Accommodative esotropia - address residual near deviation. ... - add bifocals. Specialty - add correction ...
    ... quality. Set of 16 includes 1/2, 1, 2, 4, 6, ... 50 diopter plus Red Lens. Each measures 37mm square. 4449 ... ,These prisms are of superior quality. Set of 22 includes ... 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, ...
    ... the #1 product of choice by physicians ... years. Remote control handpiece to change power ... procedural time. Dual Microprocessors: one to control ... the second to terminate activation if a ...
    ... the most powerful isolated ESU on the market ... is the only ESU that allows the surgeon ... with a standard ES pencil. Excalibur Plus PC ... necessary voltage for smooth cutting through various impedance ...
    Medicine Products: